Early PSA response is an independent prognostic factor in patients with metastatic castration-resistant prostate cancer treated with next-generation androgen pathway inhibitors.
暂无分享,去创建一个
B. Escudier | Y. Loriot | K. Fizazi | A. Patrikidou | C. Massard | L. Albiges | A. Fuerea | M. di Palma | G. Baciarello | M. Di Palma